Perspectives on the latest data for novel lipid-lowering therapies episode artwork

EPISODE · Jul 20, 2021 · 19 MIN

Perspectives on the latest data for novel lipid-lowering therapies

from touchPODCAST · host touchpodcast

touchMDT for touchCARDIO Listen to key experts from a multidisciplinary team consider the latest data for novel lipid-lowering therapies and what they may mean for their patients with dyslipidaemia  The multidisciplinary team Primary care physician: Dr Yassir Javaid, UK  Cardiologist: Dr Constantine Kosmas, USA Endocrinologist: Professor Lawrence Leiter, Canada This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Novartis Pharma AG, Basel, Switzerland. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchcardioime.org/novel-lipid-lowering-therapies-for-reducing-ASCVD-risk/

Episode metadata supplied by the publisher feed · Published Jul 20, 2021

Embed this episode

Ready to play

Perspectives on the latest data for novel lipid-lowering therapies

0:00 19:07

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of touchPODCAST?

This episode is 19 minutes long.

When was this touchPODCAST episode published?

This episode was published on July 20, 2021.

Can I download this touchPODCAST episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!